Clinical Trial Update: Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver [Phase 2]

View source ↗

Summary

A Phase 2 trial examining isolated hepatic perfusion with melphalan followed by chemotherapy in patients with unresectable colorectal cancer that has metastasiz…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Drugs mentioned

• Melphalan (Melphalan)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Recurrent Colon Cancer, Liver Metastases | Phase 2 | Status: COMPLETED